3R4L - Sequence, Chains, Asymmetric and Biological Units

• Title: HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TY
• Keywords: SERINE PROTEASE INHIBITOR, PAI-1, VERY LONG HALF LIFE, PLASM ACTIVATOR INHIBITOR TYPE 1, CARBOHYDRATE, BLOOD CLOTTING
• Experiment: X-ray diffraction
• Number of Models: 1

Database	ID code	Status	Coordinate files
			Header	Asymmetric unit	Biological unit
PDB	3R4L	released	available	available	Quaternary Structure Server

Asymmetric unit from PDB

Unit	Type	Name	Chain ID	Residues	Atoms	Hetatoms
1	Protein	PLASMINOGEN ACTIVATOR INHIBITOR 1	A	377	2995	0
2	Ligand		B	5	0	60
3	Ligand	PLASMINOGEN ACTIVATOR INHIBITOR 1	A	1	0	14
4	Water			17	0	17
total				400	2995	91

Proteins

Unit 1

HIS 26 PRO 27 PRO 28 SER 29 TYR 30 VAL 31 ALA 32 HIS 33 LEU 34 ALA 35 SER 36 ASP 37 PHE 38 GLY 39 VAL 40 ARG 41 VAL 42 PHE 43 GLN 44 GLN 45 VAL 46 ALA 47 GLN 48 ALA 49 SER 50 LYS 51 ASP 52 ARG 53 ASN 54 VAL 55 VAL 56 PHE 57 SER 58 PRO 59 TYR 60 GLY 61 VAL 62 ALA 63 SER 64 VAL 65 LEU 66 ALA 67 MET 68 LEU 69 GLN 70 LEU 71 THR 72 THR 73 GLY 74 GLY 75 GLU 76 THR 77 GLN 78 GLN 79 GLN 80 ILE 81 GLN 82 ALA 83 ALA 84 MET 85 GLY 86 PHE 87 LYS 88 ILE 89 ASP 90 ASP 91 LYS 92 GLY 93 MET 94 ALA 95 PRO 96 ALA 97 LEU 98 ARG 99 HIS 100 LEU 101 TYR 102 LYS 103 GLU 104 LEU 105 MET 106 GLY 107 PRO 108 TRP 109 ASN 110 LYS 111 ASP 112 GLU 113 ILE 114 SER 115 THR 116 THR 117 ASP 118 ALA 119 ILE 120 PHE 121 VAL 122 GLN 123 ARG 124 ASP 125 LEU 126 LYS 127 LEU 128 VAL 129 GLN 130 GLY 131 PHE 132 MET 133 PRO 134 HIS 135 PHE 136 PHE 137 ARG 138 LEU 139 PHE 140 ARG 141 SER 142 THR 143 VAL 144 LYS 145 GLN 146 VAL 147 ASP 148 PHE 149 SER 150 GLU 151 VAL 152 GLU 153 ARG 154 ALA 155 ARG 156 PHE 157 ILE 158 ILE 159 ASN 160 ASP 161 TRP 162 VAL 163 LYS 164 THR 165 HIS 166 THR 167 LYS 168 GLY 169 MET 170 ILE 171 SER 172 ASN 173 LEU 174 LEU 175 GLY 176 LYS 177 GLY 178 ALA 179 VAL 180 ASP 181 GLN 182 LEU 183 THR 184 ARG 185 LEU 186 VAL 187 LEU 188 VAL 189 ASN 190 ALA 191 LEU 192 TYR 193 PHE 194 ASN 195 GLY 196 CYS 197 TRP 198 LYS 199 THR 200 PRO 201 PHE 202 PRO 203 ASP 204 SER 205 SER 206 THR 207 HIS 208 ARG 209 ARG 210 LEU 211 PHE 212 HIS 213 LYS 214 SER 215 ASP 216 GLY 217 SER 218 THR 219 VAL 220 SER 221 VAL 222 PRO 223 MET 224 MET 225 ALA 226 GLN 227 THR 228 ASN 229 LYS 230 PHE 231 ASN 232 TYR 233 THR 234 GLU 235 PHE 236 THR 237 THR 238 PRO 239 ASP 240 GLY 241 HIS 242 TYR 243 TYR 244 ASP 245 ILE 246 LEU 247 GLU 248 LEU 249 PRO 250 TYR 251 HIS 252 GLY 253 ASP 254 THR 255 LEU 256 SER 257 MET 258 PHE 259 ILE 260 ALA 261 ALA 262 PRO 263 TYR 264 GLU 265 LYS 266 GLU 267 VAL 268 PRO 269 LEU 270 SER 271 ALA 272 LEU 273 THR 274 ASN 275 ILE 276 LEU 277 SER 278 ALA 279 GLN 280 LEU 281 ILE 282 SER 283 HIS 284 TRP 285 LYS 286 GLY 287 ASN 288 MET 289 THR 290 ARG 291 LEU 292 PRO 293 ARG 294 LEU 295 LEU 296 VAL 297 LEU 298 PRO 299 LYS 300 PHE 301 SER 302 LEU 303 GLU 304 THR 305 GLU 306 VAL 307 ASP 308 LEU 309 ARG 310 LYS 311 PRO 312 LEU 313 GLU 314 ASN 315 LEU 316 GLY 317 MET 318 THR 319 ASP 320 MET 321 PHE 322 ARG 323 GLN 324 PHE 325 GLN 326 ALA 327 ASP 328 PHE 329 THR 330 SER 331 LEU 332 SER 333 ASP 334 GLN 335 GLU 336 PRO 337 LEU 338 HIS 339 VAL 340 ALA 341 GLN 342 ALA 343 LEU 344 GLN 345 LYS 346 VAL 347 LYS 348 ILE 349 GLU 350 VAL 351 ASN 352 GLU 353 SER 354 CYS 355 THR 356 VAL 357 ALA 358 SER 359 SER 360 SER 361 THR 362 ALA 363 VAL 364 ILE 365 VAL 366 SER 367 ALA 368 ARG 369 MET 370 ALA 371 PRO 372 GLU 373 GLU 374 ILE 375 ILE 376 MET 377 ASP 378 ARG 379 PRO 380 PHE 381 LEU 382 PHE 383 VAL 384 VAL 385 ARG 386 HIS 387 ASN 388 PRO 389 THR 390 GLY 391 THR 392 VAL 393 LEU 394 PHE 395 MET 396 GLY 397 GLN 398 VAL 399 MET 400 GLU 401 PRO 402

Ligands

Unit 2	NAG 1 NAG 2 BMA 3 BMA 4 FUC 5
Unit 3	NAG 408